Ascendis Pharma A/S

ISIN DK0060615755

WKN A42ANJ

Market cap (in EUR)

14,506 m

Country

Denmark

Sector

Healthcare

Overview

Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Denmark

Financials

Key metrics

Market capitalisation, EUR	14,506 m
EPS, EUR	8.11
P/B ratio	29.3
P/E ratio	28.2
Dividend yield	-

Income statement (2025)

Revenue, EUR	720 m
Net income, EUR	-228 m
Profit margin	-31.67%

What ETF is Ascendis Pharma A/S in?

There are 20 ETFs which contain Ascendis Pharma A/S. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ascendis Pharma A/S is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weight	Investment focus	Fund size (in m EUR)
Amundi Prime Global UCITS ETF Acc	0.02%	Equity World	2,786
Invesco Nasdaq Next Generation 100 UCITS ETF Acc	0.68%	Equity United States	46
Amundi Prime Global UCITS ETF Dist	0.02%	Equity World	1,591
iShares World Equity Enhanced Active UCITS ETF EUR Hedged (Acc)	0.03%	Equity World Social/Environmental Multi-Asset Strategy	132
First Trust IPOX Europe Equity Opportunities UCITS ETF Acc	0.49%	Equity Europe IPO	1
Amundi Prime Europe UCITS ETF DR (D)	0.08%	Equity Europe	252
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing	0.00%	Equity World Multi-Factor Strategy	217
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	1.10%	Equity United States Health Care Biotech	64
iShares World Equity Enhanced Active UCITS ETF USD (Acc)	0.03%	Equity World Social/Environmental Multi-Asset Strategy	1,747
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating	0.00%	Equity World Multi-Factor Strategy	1,340
iShares Nasdaq US Biotechnology UCITS ETF	1.10%	Equity United States Health Care Biotech	958
Amundi Prime All Country World UCITS ETF GBP Hedged Dist	0.01%	Equity World	40
Amundi Prime All Country World UCITS ETF Acc	0.01%	Equity World	2,326
L&G Global Equity UCITS ETF	0.01%	Equity World Social/Environmental	1,495
L&G Europe ex UK Equity UCITS ETF	0.13%	Equity Europe Social/Environmental	471
Invesco Dow Jones Islamic Global Developed Markets UCITS ETF	0.02%	Equity World Islamic Investing	954
Xtrackers S&P Europe ex UK UCITS ETF	0.11%	Equity Europe	288
iShares World Equity Enhanced Active UCITS ETF GBP Hedged (Acc)	0.03%	Equity World Social/Environmental Multi-Asset Strategy	55
Amundi Prime All Country World UCITS ETF Dist	0.01%	Equity World	4,614
Amundi Prime Europe UCITS ETF DR (C)	0.08%	Equity Europe	226

Change your settings